During the past decade, Meridian Health Systems conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meridian Health Systems" #1 collaborator was "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Meridian Health Systems" are "Chronic Lymphocytic Leukemia (CLL)" (1 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "Meridian Health Systems" in a lesser frequency.

Most popular intervention types in "Meridian Health Systems" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "alpelisib" (1 trials), "nab-paclitaxel" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Meridian Health Systems" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Meridian Health Systems". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Meridian Health Systems, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Meridian Health Systems, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".